Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.

Shawn G KwatraGil YosipovitchFranz J LegatAdam ReichCarle PaulDagmar SimonLuigi NaldiCharles LyndeMarjolein S De Bruin-WellerWalter K NahmMaxwell SauderRola GharibSébastien BarbarotJacek C SzepietowskiCurdin ConradAlan FleischerVivian T LaquerLaurent MiseryEsther Serra-BaldrichHilde LapeereFaiz AhmadZarif K Jabbar LopezChristophe PikettySonja Ständernull null

Published in: The New England journal of medicine (2023)

Nemolizumab monotherapy significantly reduced the signs and symptoms of prurigo nodularis. (Funded by Galderma; ClinicalTrials.gov number, NCT04501679; EudraCT number, 2019-004789-17.).

Keyphrases

combination therapy
open label
randomized controlled trial
sleep quality
depressive symptoms
study protocol
double blind